Skip to main content
Clinical Trials/NCT05455333
NCT05455333
Unknown
Not Applicable

Clinical Interest of a Genetic Diagnosis in Early Infant Epilepsy, Paraclinical and Therapeutic Management, and Psychological Impact of Families

University Hospital, Strasbourg, France1 site in 1 country75 target enrollmentAugust 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Early Infant Epilepsy
Sponsor
University Hospital, Strasbourg, France
Enrollment
75
Locations
1
Primary Endpoint
Measurement of event densities
Last Updated
3 years ago

Overview

Brief Summary

To determine the paraclinical and therapeutic interest of genetic diagnosis in early onset epilepsy.

Registry
clinicaltrials.gov
Start Date
August 2022
End Date
December 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children aged ≤ 12 years,
  • hospitalized or followed at the Hautepierre Hospital of the University Hospitals of Strasbourg for primary epilepsy having started in the first 5 months of life, from 2010 to 2021.

Exclusion Criteria

  • Children with secondary epilepsy (with infection trauma)

Outcomes

Primary Outcomes

Measurement of event densities

Time Frame: 4 month

The frequency of events (crises, going to the emergency room, hospitalizations) before and after genetic diagnosis.

Study Sites (1)

Loading locations...

Similar Trials